Moderna’s phase one clinical trial data shows all 45 participants developed antibodies that could fight the coronavirus. The vaccine will move into large-scale human trials later this month, enrolling 30,000 participants. When could an effective vaccine be ready for the masses? And will there be enough available? NBC News medical correspondent Dr. John Torres has this week’s Sunday Spotlight.
» Subscribe to TODAY:
» Watch the latest from TODAY:

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY’s Website:
Find TODAY on Facebook:
Follow TODAY on Twitter:
Follow TODAY on Instagram:
Follow TODAY on Pinterest:

#Coronavirus #SundayTODAY

Inside The Rush To Develop A Coronavirus Vaccine | Sunday TODAY